PL371297A1 - Method of treating depression with delta receptor agonist compounds - Google Patents
Method of treating depression with delta receptor agonist compoundsInfo
- Publication number
- PL371297A1 PL371297A1 PL02371297A PL37129702A PL371297A1 PL 371297 A1 PL371297 A1 PL 371297A1 PL 02371297 A PL02371297 A PL 02371297A PL 37129702 A PL37129702 A PL 37129702A PL 371297 A1 PL371297 A1 PL 371297A1
- Authority
- PL
- Poland
- Prior art keywords
- receptor agonist
- treating depression
- agonist compounds
- delta receptor
- delta
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000000841 delta opiate receptor agonist Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34008401P | 2001-10-29 | 2001-10-29 | |
| US33788701P | 2001-11-02 | 2001-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL371297A1 true PL371297A1 (en) | 2005-06-13 |
Family
ID=26990913
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL02371297A PL371297A1 (en) | 2001-10-29 | 2002-10-29 | Method of treating depression with delta receptor agonist compounds |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7030124B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1450807B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4892654B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1596113B (cg-RX-API-DMAC7.html) |
| CA (1) | CA2464471C (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA04004059A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20042257L (cg-RX-API-DMAC7.html) |
| PL (1) | PL371297A1 (cg-RX-API-DMAC7.html) |
| RU (1) | RU2314809C2 (cg-RX-API-DMAC7.html) |
| TW (1) | TW200300089A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2003037342A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1269805C (zh) * | 2001-05-18 | 2006-08-16 | 阿斯特拉曾尼卡有限公司 | 4-(苯基-哌嗪基-甲基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
| US8476280B2 (en) * | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| SE0203300D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| US7314880B2 (en) * | 2003-01-02 | 2008-01-01 | Mount Cook Biosciences, Inc. | Cardioprotective delta opioid receptor agonists and methods of using same |
| NZ593444A (en) | 2003-10-01 | 2012-12-21 | Adolor Corp | 4-[(2-N,N-diethylaminocarbonyl)pyrid-5-yl]-spiro[1,2-dihydronaphthalene-2,4'-piperidine] and methods of its use |
| MX2007001240A (es) * | 2004-08-02 | 2007-03-23 | Astrazeneca Ab | Derivados de diarilmetil-piperazina, preparaciones y usos de las mismas. |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| US7598261B2 (en) | 2005-03-31 | 2009-10-06 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| US7683168B2 (en) * | 2005-04-14 | 2010-03-23 | Mount Cook Bio Sciences, Inc. | Compositions of novel opioid compounds and method of use thereof |
| TW200803856A (en) | 2005-09-02 | 2008-01-16 | Mount Cook Biosciences Inc | Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity |
| US7576207B2 (en) | 2006-04-06 | 2009-08-18 | Adolor Corporation | Spirocyclic heterocyclic derivatives and methods of their use |
| NZ590041A (en) * | 2008-05-20 | 2012-11-30 | Astrazeneca Ab | Method of treating anxious major depressive disorder |
| CN103467460A (zh) * | 2013-09-23 | 2013-12-25 | 昆明理工大学 | 一类含噻吩环和苄基的二芳基甲基哌嗪化合物及其应用 |
| CN105646151B (zh) * | 2016-02-26 | 2018-06-29 | 山西大学 | 一种炔类化合物及其制备方法和该化合物的用途 |
| WO2017173067A1 (en) | 2016-03-31 | 2017-10-05 | Versi Group, Llc | Delta opioid agonist, mu opioid antagonist compositions and methods for treating parkinson's disease |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5A (en) * | 1836-08-10 | Thomas Blanchard | Machine for mortising solid wooden shells of ships' tackle-blocks | |
| US5807858A (en) * | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
| US5681830A (en) * | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
| US5574159A (en) * | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| US5985880A (en) * | 1996-06-05 | 1999-11-16 | Delta Pharmaceuticals | Compositions and methods for reducing respiratory depression and attendant side effects of mu opioid compounds |
| US20020052007A1 (en) * | 1992-02-03 | 2002-05-02 | Chang Kwen Jen | Diarylmethylbenzylpiperazines and corresponding halobenzyl derivatives |
| AU692788B2 (en) * | 1993-07-30 | 1998-06-18 | Ardent Pharmaceuticals, Inc. | Piperazine compounds used in therapy |
| US6046200A (en) * | 1994-09-09 | 2000-04-04 | The United States Of America As Represented By The Secretary Of The Army | Compositions having neuroprotective and analgesic activity |
| SE9504661D0 (sv) | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| GB9709972D0 (en) * | 1997-05-19 | 1997-07-09 | Pfizer Ltd | Tetrazoles |
| GB9804734D0 (en) * | 1998-03-05 | 1998-04-29 | Pfizer Ltd | Compounds |
| ATE273970T1 (de) * | 1998-04-16 | 2004-09-15 | Pfizer Prod Inc | N-acyl und n-aroyl aralkylamide |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904675D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| GB0017256D0 (en) * | 2000-07-13 | 2000-08-30 | Merck Sharp & Dohme | Therapeutic agents |
| CN1269805C (zh) | 2001-05-18 | 2006-08-16 | 阿斯特拉曾尼卡有限公司 | 4-(苯基-哌嗪基-甲基)-苯甲酰胺衍生物及其在治疗疼痛、焦虑症或胃肠病中的应用 |
-
2002
- 2002-10-29 CN CN028237099A patent/CN1596113B/zh not_active Expired - Fee Related
- 2002-10-29 WO PCT/US2002/034421 patent/WO2003037342A1/en not_active Ceased
- 2002-10-29 RU RU2004115748/14A patent/RU2314809C2/ru not_active IP Right Cessation
- 2002-10-29 PL PL02371297A patent/PL371297A1/xx unknown
- 2002-10-29 EP EP02789294.2A patent/EP1450807B1/en not_active Expired - Lifetime
- 2002-10-29 JP JP2003539685A patent/JP4892654B2/ja not_active Expired - Fee Related
- 2002-10-29 CA CA2464471A patent/CA2464471C/en not_active Expired - Fee Related
- 2002-10-29 US US10/282,411 patent/US7030124B2/en not_active Expired - Fee Related
- 2002-10-29 MX MXPA04004059A patent/MXPA04004059A/es unknown
- 2002-10-29 TW TW091132060A patent/TW200300089A/zh unknown
-
2004
- 2004-06-01 NO NO20042257A patent/NO20042257L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2003037342A1 (en) | 2003-05-08 |
| CN1596113B (zh) | 2010-05-26 |
| TW200300089A (en) | 2003-05-16 |
| US7030124B2 (en) | 2006-04-18 |
| CA2464471C (en) | 2012-05-15 |
| MXPA04004059A (es) | 2005-03-31 |
| EP1450807B1 (en) | 2013-12-25 |
| CN1596113A (zh) | 2005-03-16 |
| US20030144299A1 (en) | 2003-07-31 |
| CA2464471A1 (en) | 2003-05-08 |
| RU2314809C2 (ru) | 2008-01-20 |
| EP1450807A4 (en) | 2008-06-25 |
| JP2005508363A (ja) | 2005-03-31 |
| EP1450807A1 (en) | 2004-09-01 |
| NO20042257L (no) | 2004-06-24 |
| RU2004115748A (ru) | 2005-03-27 |
| JP4892654B2 (ja) | 2012-03-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1450807A4 (en) | PROCESS FOR TREATING DEPRESSION WITH DELTA RECEPTOR AGONIST COMPOUNDS | |
| EP1405219A4 (en) | METHOD AND DEVICES FOR BUSINESS APPLICATION INTEGRATION | |
| PL357927A1 (en) | Method of obtaining trimethylpropane | |
| IL147695A0 (en) | Method of treating certain cancers using an estrogen agonist/antagonist | |
| GB0128287D0 (en) | Novel method and compounds | |
| AU2002302243A1 (en) | Method for determination of co-occurences of attributes | |
| IL146598A0 (en) | Method for the preparation of aggregates | |
| PL353299A1 (en) | Method of obtaining unsaturated silico-organic compounds | |
| IL161073A0 (en) | Composition and method for treating diabetes | |
| GB2366639B (en) | Method of comparing parts | |
| AU2003214800A1 (en) | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds | |
| AU2002361357A8 (en) | Method for monosulphonylation of an aminobenzofuran compound | |
| GB0129008D0 (en) | Method for forming matrices of hardened material | |
| PL352866A1 (en) | Novel isoindoloindolone compounds, method of obtaining tehm and pharmacological compoistion containing such compounds | |
| GB0113408D0 (en) | Autocatalytic coating method | |
| AU2002352120A8 (en) | Coating method | |
| AU2002353369A8 (en) | Anti-pirate method for the distribution of digital content | |
| SG96641A1 (en) | Method of electro-coating an article | |
| HUP0401146A3 (en) | Method for producing alkyl nitrites and alkyl dinitrites | |
| AU2002366272A8 (en) | Edg-receptor agonist for the treatment of hypertension | |
| HU0100572D0 (en) | Method for elimination of graphiti from big surface | |
| HU0100184V0 (en) | Method for forming of smokingset | |
| HU0100382D0 (en) | Method for determining dispersion of dimension of granules of polidisperse materials | |
| GB0203197D0 (en) | Delta opioid agonists | |
| PL356317A1 (en) | Method of obtaining alkanosulphonylpyridines |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DISC | Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications) |